Experimental cell shot aims to tame failing livers
NCT ID NCT07488546
First seen Apr 13, 2026 · Last updated May 22, 2026 · Updated 6 times
Summary
This early-stage trial tests a single injection of HCL001 cells in 39 adults with decompensated cirrhosis, a severe form of liver disease. The main goal is to check safety and find the right dose, with early signs of effectiveness also measured. Participants must have a diagnosis of cirrhosis from causes like hepatitis or alcohol use, and be in fair overall health. This is not a cure, but aims to control the disease and improve liver function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DECOMPENSATED CIRRHOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospita
Shanghai, Shanghai Municipality, China
Conditions
Explore the condition pages connected to this study.